Cargando…
Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies
Multi-drug and extensively drug resistant tuberculosis (M/XDR-TB) has been an area of growing concern among clinicians, epidemiologists, and public health workers worldwide. Lack of controlled trials in M/XDR-TB patients hinders the optimal management of such patients, and guidelines that have been...
Autor principal: | Prasad, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354490/ https://www.ncbi.nlm.nih.gov/pubmed/22628931 http://dx.doi.org/10.4103/0970-2113.95321 |
Ejemplares similares
-
Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management
por: Prasad, Rajendra, et al.
Publicado: (2017) -
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018) -
Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
por: Eker, Barbara, et al.
Publicado: (2008) -
Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid
por: Pecora, Francesco, et al.
Publicado: (2021) -
Multidrug and extensively drug-resistant tuberculosis from a general practice perspective
por: Yashodhara, BM, et al.
Publicado: (2010)